89.75
Lemaitre Vascular Inc stock is traded at $89.75, with a volume of 103.01K.
It is up +1.98% in the last 24 hours and down -2.71% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$88.01
Open:
$87.68
24h Volume:
103.01K
Relative Volume:
0.62
Market Cap:
$2.03B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
49.04
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
+2.71%
1M Performance:
-2.71%
6M Performance:
+5.94%
1Y Performance:
+1.28%
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LMAT
Lemaitre Vascular Inc
|
89.75 | 1.99B | 213.03M | 41.32M | 33.49M | 1.83 |
![]()
ISRG
Intuitive Surgical Inc
|
462.74 | 164.35B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
189.03 | 54.75B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
268.22 | 39.61B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
75.76 | 37.31B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
279.39 | 19.77B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
Aug-02-24 | Resumed | Lake Street | Buy |
May-31-24 | Resumed | ROTH MKM | Buy |
Apr-26-24 | Upgrade | Stifel | Hold → Buy |
Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-06-23 | Initiated | Oppenheimer | Outperform |
Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Sep-16-21 | Initiated | Jefferies | Buy |
Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
Jul-25-19 | Reiterated | Barrington Research | Outperform |
Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
Jun-08-18 | Resumed | ROTH Capital | Buy |
Apr-26-18 | Downgrade | Stifel | Buy → Hold |
Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
Mar-21-17 | Initiated | First Analysis Sec | Overweight |
Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
Jul-28-16 | Reiterated | Barrington Research | Outperform |
Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
How to read the order book for LeMaitre Vascular Inc.Weekly Market Report & Safe Capital Growth Tips - newser.com
Will LeMaitre Vascular Inc. (LHU) stock announce special dividend2025 Price Momentum & AI Enhanced Trading Alerts - newser.com
What hedge fund moves indicate for LeMaitre Vascular Inc. (LHU) stockEarnings Growth Summary & Verified Momentum Watchlists - newser.com
Best data tools to analyze LeMaitre Vascular Inc. stock2025 Top Decliners & Verified Swing Trading Watchlist - newser.com
How LeMaitre Vascular Inc. (LHU) stock reacts to Fed tightening2025 Market Trends & Weekly Consistent Profit Watchlists - newser.com
LeMaitre Vascular, Inc. (LMAT): Investor Outlook On A 18.88% Potential Upside - DirectorsTalk Interviews
Using data models to predict LeMaitre Vascular Inc. stock movementJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
LeMaitre Vascular Inc. stock momentum explainedJuly 2025 Review & Real-Time Chart Breakout Alerts - newser.com
Using economic indicators to assess LeMaitre Vascular Inc. potential2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Published on: 2025-10-20 21:28:11 - newser.com
Published on: 2025-10-20 20:48:06 - newser.com
How hedge fund analytics apply to LeMaitre Vascular Inc. stockJuly 2025 Short Interest & AI Driven Stock Reports - newser.com
Is LeMaitre Vascular Inc. forming a bottoming baseGold Moves & Daily Entry Point Alerts - newser.com
How LeMaitre Vascular Inc. (LHU) stock reacts to fiscal policies2025 Short Interest & Precise Trade Entry Recommendations - nchmf.gov.vn
Conestoga Capital Advisors LLC Decreases Stock Holdings in LeMaitre Vascular, Inc. $LMAT - Defense World
When is the best time to exit LeMaitre Vascular Inc.Market Volume Summary & Entry and Exit Point Strategies - newser.com
What technical patterns form on LeMaitre Vascular Inc. (LHU) stock chartsGold Moves & AI Enhanced Trading Signals - newser.com
What’s next for LeMaitre Vascular Inc. stock priceJuly 2025 Final Week & Real-Time Volume Spike Alerts - newser.com
Avoiding Lag: Real-Time Signals in (LMAT) Movement - news.stocktradersdaily.com
LeMaitre Vascular’s (LMAT) Outperform Rating Reiterated at Barrington Research - Defense World
Will a bounce in LeMaitre Vascular Inc. offer an exitPortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
LeMaitre Vascular, Inc.Common Stock (NQ: LMAT - FinancialContent
Is LeMaitre Vascular Inc. stock attractive for passive investorsMarket Performance Summary & Real-Time Chart Breakout Alerts - nchmf.gov.vn
Values First Advisors Inc. Decreases Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. (LMAT) Stock forecasts - Yahoo
LeMaitre Vascular, Inc. (LMAT) stock forecast and price target - Yahoo
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo Finance
Regression analysis insights on LeMaitre Vascular Inc. performanceJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Signal strength of LeMaitre Vascular Inc. stock in tech scanners2025 AllTime Highs & Technical Confirmation Alerts - newser.com
Volatility clustering patterns for LeMaitre Vascular Inc.Watch List & Real-Time Market Sentiment Reports - newser.com
LeMaitre Vascular (LMAT) Analyst Ratings Unchanged by Barrington Research | LMAT Stock News - GuruFocus
LeMaitre Vascular's (LMAT) Outperform Rating Reaffirmed at Barrington Research - MarketBeat
What MACD and RSI say about LeMaitre Vascular Inc.2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
Vest Financial LLC Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Detecting price anomalies in LeMaitre Vascular Inc. with AIIndex Update & Technical Pattern Based Buy Signals - newser.com
Is a relief rally coming for LeMaitre Vascular Inc. holdersDollar Strength & Fast Moving Stock Trade Plans - newser.com
Smart tools for monitoring LeMaitre Vascular Inc.’s price action2025 Bull vs Bear & Growth-Oriented Investment Plans - newser.com
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Healthcare Innovator with 22.64% Potential Upside - DirectorsTalk Interviews
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):